Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- W. Conshohocken, Pennsylvania
- Most recent report
- 10-Q, filed Nov 6, 2026
- Incorporated
- N/A
- Filings on record
- 347 filings
- On EDGAR
- CIK 1997296
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 16
News 8 of 36
- 8-K Current report on a material event Nov 4, 2026
- 8-K Other events Oct 23, 2026
- 8-K Current report on a material event Oct 16, 2026
- 8-K Other events Oct 7, 2026
- 8-K Current report on a material event Sep 14, 2026
- 8-K Current report on a material event Sep 11, 2026
- 8-K Significant contract Sep 3, 2026
- 8-K Shareholder vote results Jun 4, 2026
Prospectuses and Registrations 8 of 109
- 424B3 Prospectus supplement for an offering Nov 6, 2026
- 424B3 Prospectus supplement for an offering Oct 26, 2026
- 424B3 Prospectus supplement for an offering Oct 16, 2026
- 424B3 Prospectus supplement for an offering Oct 7, 2026
- 424B3 Prospectus supplement for an offering Sep 14, 2026
- 424B3 Prospectus supplement for an offering Sep 3, 2026
- 424B3 Prospectus supplement for an offering Aug 13, 2026
- 424B3 Prospectus supplement for an offering Jun 4, 2026
Proxies 6
- DEF 14A Proxy statement for a shareholder vote Oct 30, 2026
- PRE 14A Preliminary proxy statement Oct 19, 2026
- DEF 14A Proxy statement for a shareholder vote May 4, 2026
- PRE 14A Preliminary proxy statement Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 30, 2025
- PRE 14A Preliminary proxy statement Jun 13, 2025
Ownership 8 of 96
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 16, 2026
- SCHEDULE 13D Large holder reported an active stake Sep 14, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Jun 4, 2026
Other 8 of 84
- 425 Nov 9, 2026
- 425 Nov 6, 2026
- 425 Nov 4, 2026
- ARS Annual report sent to shareholders May 4, 2026
- EFFECT Notice that a registration became effective Mar 27, 2026
- EFFECT Notice that a registration became effective Mar 27, 2026
- EFFECT Notice that a registration became effective Mar 27, 2026
- 253G2 Mar 6, 2026
Everything here comes from Medicus Pharma Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.